Sorry, you need to enable JavaScript to visit this website.

A Study to Measure Whether PF-06480605 is Safe and Effective in the Treatment of Moderate to Severe Ulcerative Colitis

A Phase 2a, Multicenter, Single Arm, Open-Label, Two-Stage, Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis

Category & Conditions: Immune System Diseases and Conditions
Medicine: PF-06480605
ClinicalTrials.gov Identifier (NCT): NCT02840721
Protocol ID: B7541002
    Share
PrintDownload
Open Plain Language Summary Result: Click here